- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on HER2-positive Primary Malignancy in Korea, Republic of
Total 195 results
-
Samsung Medical CenterCompletedHER2-positive Refractory Advanced CancerKorea, Republic of
-
Gangnam Severance HospitalSeoul National UniversityRecruitingBreast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive Tumor | Premenopausal Breast Cancer | Node-positive Breast CancerKorea, Republic of
-
Alteogen, Inc.CompletedHER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterRecruitingHER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterUnknownHER2-positive Breast CancerKorea, Republic of
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
National Cancer Center, KoreaActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingHER2-positive Breast Cancer | Chemotherapy Effect | Circulating Tumor DNAKorea, Republic of
-
Yonsei UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | PostmenopausalKorea, Republic of
-
Yonsei UniversityNot yet recruitingHER2-positive Gastric CancerKorea, Republic of
-
Kangbuk Samsung HospitalRecruitingHER2-positive Advanced Gastric CancerKorea, Republic of
-
Yonsei UniversityCompletedHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Yonsei UniversityNot yet recruitingHER2 Positive Advanced/Metastatic/Nonresectable Biliary Tract CancerKorea, Republic of
-
Gangnam Severance HospitalSamsung Medical Center; Asan Medical Center; Severance HospitalRecruitingBreast Cancer | Surgery | Recurrent Breast Cancer | Estrogen Receptor Positive Tumor | Stereotactic Body Radiotherapy | Her2-negative TumorKorea, Republic of
-
Seoul National University HospitalCompletedHormone Receptor Positive Malignant Neoplasm of BreastKorea, Republic of
-
Yuhan CorporationRecruitingHER2-Positive Solid TumorKorea, Republic of, Australia
-
Samsung Medical CenterCompletedHER2-positive Gastric Cancer Patients With Liver MetastasisKorea, Republic of
-
Hanmi Pharmaceutical Company LimitedNational OncoVentureCompletedHER-2 Positive Advanced Gastric CancerKorea, Republic of
-
Sung Yong OhCelltrionUnknownMetastatic Cancer | HER-2 Positive Gastric CancerKorea, Republic of
-
Asan Medical CenterHoffmann-La RocheCompletedMetastatic or Recurrent Gastric Adenocarcinoma | Her-2 Positive Gastric CancerKorea, Republic of
-
Yonsei UniversityRecruitingTriple Negative Breast Cancer | Metastatic Breast Cancer With HER2 PositiveKorea, Republic of
-
Bolt Biotherapeutics, Inc.Bristol-Myers SquibbActive, not recruitingHER2-positive Breast Cancer | HER2-positive Colorectal Cancer | HER2-positive Solid Tumors | HER2-positive Gastroesophageal Cancer | HER2-positive Endometrial CancerFrance, United States, Spain, Korea, Republic of, Italy
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
EnhancedBio USA Inc.ZenopharmRecruitingMetastatic Breast Cancer | Locally Advanced Breast Cancer | HER2-Negative | Estrogen Receptor-PositiveUnited States, Korea, Republic of
-
Asan Medical CenterUnknownMalignant Ureteral ObstructionKorea, Republic of
-
Seoul National University Bundang HospitalUnknownBreast Neoplasm Malignant PrimaryKorea, Republic of
-
Seoul National University HospitalTerminatedVery Low Birth Weight Infant | Ureaplasma/Mycoplasma PositiveKorea, Republic of
-
Seoul National University Bundang HospitalUnknownMalignant Female Reproductive System NeoplasmKorea, Republic of
-
Gangnam Severance HospitalCompletedMalignant TumorKorea, Republic of
-
Yonsei UniversityCompletedPrimary Lung TuberculosisKorea, Republic of
-
Pieris Pharmaceuticals, Inc.Active, not recruitingHER2-positive Gastric CancerUnited States, Korea, Republic of
-
Silverback TherapeuticsActive, not recruitingHER2 Positive Solid TumorsUnited States, Korea, Republic of, Australia
-
Seoul National University HospitalTerminatedMetastatic Malignant Melanoma and Renal Cell CarcinomaKorea, Republic of
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
CinnagenCompletedHER2-positive Breast CancerIran, Islamic Republic of
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast Cancer or Gastric CancerTaiwan, Netherlands, Italy, United States, Belgium, United Kingdom, Korea, Republic of, France, Spain
-
Enliven TherapeuticsRecruitingHER2-positive Metastatic Breast Cancer | HER2 Gene Mutation | HER2 Mutant Non-small Cell Lung Cancer | HER2 AmplificationSpain, United States, Korea, Republic of, Taiwan, Italy, Australia, France
-
Asan Medical CenterUnknownStomach Cancer | Hepatocellular Carcinoma | Pancreatic Cancer | Esophageal Cancer | Duodenal Cancer | Esophagogastric Junction Cancer | Cancer-associated Thrombosis | Ampulla of Vater Cancer | Malignant Gastrointestinal Stromal Tumor | Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)Korea, Republic of
-
OmicsWay Corp.Oncobox Ltd., Russia; Vitamed LLC, Russia; Republican Oncological Dispensary...Active, not recruitingHER2-positive Breast CancerUnited States, Russian Federation
-
PrecirixTerminatedAdvanced/Metastatic HER2-positive Breast, Gastric, Gastroesophageal Junction Cancer With Disease Progression Following Anti-HER2 Standard of Care TreatmentUnited States, Canada
-
Celularity IncorporatedActive, not recruitingMetastatic HER2 Positive Gastroesophageal Junction CancerUnited States
-
GeneMedicine Co., Ltd.RecruitingRenal Cell Carcinoma | Cervical Cancer | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Malignant MelanomaKorea, Republic of
-
Kyoto Breast Cancer Research NetworkPfizerCompletedHormone Receptor Positive Malignant Neoplasm of Breast | Breast Cancer FemaleTaiwan, Japan, Korea, Republic of, Australia, Hong Kong
-
Medstar Health Research InstituteGenentech, Inc.CompletedLeft Ventricular Function Systolic Dysfunction | HER2 Positive Breast CancerUnited States
-
Ambrx, Inc.RecruitingHER2 Positive Metastatic Breast CancerUnited States, Korea, Republic of, France, Australia
-
AstraZenecaRecruitingER+ HER2- Advanced Breast Cancer | High-grade Serous Ovarian Cancer (HGSOC)United States, United Kingdom, Korea, Republic of, Australia, Spain
-
CytomX TherapeuticsCompletedNeoplasms | Breast Cancer | Breast Neoplasms | Breast Neoplasms, Triple-Negative | Breast Neoplasms, Hormone Receptor Positive/HER2 NegativeUnited States, Spain, Korea, Republic of
-
AstraZenecaActive, not recruitingAdvanced ER-Positive HER2-Negative Breast CancerUnited States, Italy, Spain, Belgium, Poland, Canada, Germany, Korea, Republic of, Russian Federation, France, Israel, Hungary, Portugal, United Kingdom, Georgia, Ukraine